(Z)-PHENYL(PYRIDIN-4-YL)METHANONE OXIME, 95.0%, 1g

8-Fluoro-1-methylisoquinoline, 98%, 1g

4-Methoxybenzyl (1S,2S)-2-((R)-4-((9H-xanthen-9-yl)methyl)-1-(4-methoxybenzyl)-2,5-dioxoimidazolidin-4-yl)cyclopropane-1-carboxylate, 98%, 250mg

(2-Methoxyethyl)[(5-methyl-2-thienyl)methyl]amine hydrochloride, 95.0%, 5g

3-Butylpyridine, 95.0%, 100mg

Propargyl Sulfide>98.0%(GC)5g

rac trans-2,5-Dimethylpyrrolidine x HCl, 90.0%, 1g

[1-(2-methoxyethyl)pyrrolidin-3-yl]methanol, 95.0%, 10g

L-Lysine 13C6 Hydrochloride, min. 98% 13C, 100 mg, glass packaging

5-Amino-2-chlorobenzenesulfonamide, 97.0%, 100mg

N-Methoxy-N-methyl-1H-imidazole-1-carboxamide>95.0%(GC)200mg

tert-Butyl 5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)nicotinate, 95+%, 250mg

GC capillary column ROTI®Cap-1701, 25 m, 0.32 mm, 1.00 µm, 1 Piece(s)